PC c.115_116delinsGC ;(p.K39A)

Variant ID: 11-66639515-TT-GC

NM_001040716.1(PC):c.115_116delinsGC;(p.K39A)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Optogenetic Control of PIP2 Interactions Shaping ENaC Activity.

International Journal Of Molecular Sciences
Abd El-Aziz, Tarek Mohamed TM; Kaur, Amanpreet A; Shapiro, Mark S MS; Stockand, James D JD; Archer, Crystal R CR
Publication Date: 2022-03-31

Variant appearance in text: PC: K39A
PubMed Link: 35409240
Variant Present in the following documents:
  • Main text
  • ijms-23-03884.pdf
View BVdb publication page



Molecular Analysis of Membrane Targeting by the C2 Domain of the E3 Ubiquitin Ligase Smurf1.

Biomolecules
Scott, Jordan L JL; Frick, Cary T CT; Johnson, Kristen A KA; Liu, Haining H; Yong, Sylvia S SS; Varney, Allyson G AG; Wiest, Olaf O; Stahelin, Robert V RV
Publication Date: 2020-02-04

Variant appearance in text: PC: K39A
PubMed Link: 32033048
Variant Present in the following documents:
  • biomolecules-10-00229.pdf
View BVdb publication page



Human β-defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation.

Oncotarget
Phan, Thanh Kha TK; Lay, Fung T FT; Poon, Ivan K H IK; Hinds, Mark G MG; Kvansakul, Marc M; Hulett, Mark D MD
Publication Date: 2016-01-12

Variant appearance in text: PC: K39A
PubMed Link: 26657293
Variant Present in the following documents:
  • Main text
  • oncotarget-07-2054.pdf
View BVdb publication page



Molecular determinants of PI(4,5)P2 and PI(3,4,5)P3 regulation of the epithelial Na+ channel.

The Journal Of General Physiology
Pochynyuk, Oleh O; Tong, Qiusheng Q; Medina, Jorge J; Vandewalle, Alain A; Staruschenko, Alexander A; Bugaj, Vladislav V; Stockand, James D JD
Publication Date: 2007-10

Variant appearance in text: PC: K39A
PubMed Link: 17893193
Variant Present in the following documents:
  • Main text
View BVdb publication page